These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11689585)

  • 1. Pilot study of low-dose interleukin-11 in patients with bone marrow failure.
    Kurzrock R; Cortes J; Thomas DA; Jeha S; Pilat S; Talpaz M
    J Clin Oncol; 2001 Nov; 19(21):4165-72. PubMed ID: 11689585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.
    Tsimberidou AM; Giles FJ; Khouri I; Bueso-Ramos C; Pilat S; Thomas DA; Cortes J; Kurzrock R
    Ann Oncol; 2005 Jan; 16(1):139-45. PubMed ID: 15598951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
    Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia.
    Nimer SD; Paquette RL; Ireland P; Resta D; Young D; Golde DW
    Exp Hematol; 1994 Aug; 22(9):875-80. PubMed ID: 8062886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A; Shibata A
    Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of recombinant human interleukin 11 on thrombocytopenia in pre-aplastic anemia].
    Shang AF; Guo JM; Shang JD; Liu XH; Ai H; Zhu L; Zheng YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):151-3. PubMed ID: 15748457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
    Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
    J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome.
    Montero AJ; Estrov Z; Freireich EJ; Khouri IF; Koller CA; Kurzrock R
    Leuk Lymphoma; 2006 Oct; 47(10):2049-54. PubMed ID: 17071475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expert consensus on rational use of recombinant human IL-11 for thrombocytopenia in solid tumor patients].
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):948-9. PubMed ID: 21223808
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematologic response in patients with aplastic anemia after long-term administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.
    Yonekura S; Kawada H; Watanabe S; Masumoto A; Ogawa Y; Fukuda R; Nishihira H; Matsuyama S; Katoh S; Mouri H; Motomura S; Shionoya S; Hotta T
    Clin Ther; 1997; 19(6):1394-407. PubMed ID: 9444448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of subcutaneous administration of interleukin-1 beta on blood platelet count and serum GM-CSF in patients with myelodysplastic syndrome and aplastic anemia].
    Furuya H; Ishibashi R; Wakayama T; Ohguni S; Notsu K; Takagi C; Kato Y
    Rinsho Ketsueki; 1992 Sep; 33(9):1172-7. PubMed ID: 1433938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
    Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP
    Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful bone marrow plus cord blood stem cell transplantation in a girl who developed myelodysplastic syndrome from hepatitis-associated aplastic anemia treated with long-term immunosuppressants and growth factors.
    Shibuya A; Ishii S; Obinata K
    Hematology; 2002 Oct; 7(5):301-4. PubMed ID: 12850817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.
    Ganser A; Seipelt G; Verbeek W; Ottmann OG; Maurer A; Kolbe K; Hess U; Elsner S; Reutzel R; Wörmann B
    Leukemia; 1994 Mar; 8(3):369-75. PubMed ID: 7510354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
    Sieff C; Guinan E
    Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.